ROQUEFORT THERAPEUTICS PLC
Biotechnology company developing medicines for therapy-resistant cancers.
ROQ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMDQ2T15
- LEI:
- 254900P4SISIWOR9RH34
- Country:
- United Kingdom
- Address:
- 85 Great Portland Street, W1W 7LT London
- Website:
- https://www.roquefortplc.com/
Description
Roquefort Therapeutics PLC is a biotechnology company focused on developing next-generation, first-in-class medicines for hard-to-treat cancers. The company operates within the high-growth immuno-oncology market. Its portfolio consists of five novel, patent-protected, pre-clinical anti-cancer programs. These programs are designed to target cancers that have become resistant to existing therapies. Roquefort Therapeutics utilizes a distributed R&D model, combining its in-house expertise and laboratory facilities with a network of partnerships with leading academic cancer research centers to advance its development strategy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-19 08:00 |
STAT-6 siRNA Demonstrates Efficacy in Immunology
|
English | 17.4 KB | ||
| 2024-09-02 08:00 |
Grant of MK Cell Patent & Licencing Update
|
English | 20.4 KB | ||
| 2024-06-27 13:46 |
Results of AGM
|
English | 25.6 KB | ||
| 2024-06-20 08:00 |
Appointment of Broker
|
English | 14.1 KB | ||
| 2024-06-04 08:00 |
Notice of Annual General Meeting
|
English | 12.0 KB | ||
| 2024-05-23 08:05 |
Issue of Convertible Loan Notes & Board Changes
|
English | 18.5 KB | ||
| 2024-05-23 08:00 |
Midkine Antibody Licencing Deal
|
English | 18.8 KB | ||
| 2024-04-26 15:48 |
Annual Report & Financial Statements - 31 Dec 2023
|
English | 921.0 KB | ||
| 2024-04-26 08:00 |
Annual Report & Financial Statements - 31 Dec 2023
|
English | 731.9 KB | ||
| 2024-04-05 08:00 |
Response to Share Price Movement
|
English | 12.7 KB | ||
| 2024-03-11 08:00 |
Positive Results: Midkine mRNA and STAT-6 siRNA
|
English | 21.5 KB | ||
| 2024-02-06 08:00 |
Operations Update
|
English | 17.3 KB | ||
| 2023-11-24 08:00 |
Change of Auditor
|
English | 13.0 KB | ||
| 2023-11-06 08:00 |
Significant Mesodermal Killer Cell Milestone
|
English | 18.6 KB | ||
| 2023-09-27 08:00 |
Interim Results to 30 June 2023
|
English | 233.2 KB |
Automate Your Workflow. Get a real-time feed of all ROQUEFORT THERAPEUTICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ROQUEFORT THERAPEUTICS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ROQUEFORT THERAPEUTICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
